BackEliem Therapeutics Overview

Eliem Therapeutics Net Income

Profitability analysis for ELYM.

Quarterly Net Income

-$13.72M
33.97% YoY

As of Mar 2026

Annual Net Income (TTM)

-$52.79M
46.26% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...